Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

0.30
Delayed Data
As of 3:59pm ET
 +0.0029 / +0.98%
Today’s Change
0.27
Today|||52-Week Range
1.05
-70.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues34.4M11.5M15.2M4.4M
 
 
 
 
 
Cost of Goods Sold4.5M1.9M5.9M0.00
 
 
 
 
Depreciation And Amortization3.7M3.5M3.1M2.4M
 
 
 
 
 
 
Operating ExpensesGross Income26.3M6.1M6.1M2.0M
 
 
 
 
 
General Expenses37.5M40.7M38.4M30.5M
 
 
 
 
 
Research And Development28.7M33.3M29.8M24.9M
 
 
 
 
 
Total Operating Expenses45.6M46.1M47.5M32.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.2M-34.6M-32.3M-28.5M
 
 
 
 
 
Extraordinary Charge-1.0M-1.0M-1.0M0.00
 
 
 
 
Interest Expense On Debt0.00674.0K4.9M3.7M
 
 
 
 
Other Expenses0.008.5M8.1M4.9M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.6M-27.8M-29.9M-27.3M
 
 
 
 
 
Discontinued Operations0.000.000.0045.4M
 
 
Extraordinary Items0.000.000.0039.9M
 
 
Net Income-11.6M-27.8M-29.9M18.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS90.8M92.4M92.9M94.9M
 
 
 
 
 
Shares To Calculate EPS Diluted90.8M92.4M92.9M94.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.13-$0.30-$0.32$0.61
 
 
 
 
 
EPS Diluted-$0.13-$0.30-$0.32$0.19